Showing 1 - 10 of 10 Bincy Abraham

Status: Open Not Enrolling

Investigator: Bincy Abraham

Study Coordinator: Mayyadah Al-Sabbagh

Phone: 346.238.0307

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label. ... Read more >

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Alejandro De La Torre

Phone: 713.441.6396

This is a study to demonstrate the effect of oral ozanimod as maintenance therapy in participants with moderately to severely active Crohn's Disease. ... Read more >

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator:

Phone:

The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of guselkumab in participants with Crohn's disease. ... Read more >

Status: Open Not Enrolling

Investigator: Bincy Abraham

Study Coordinator: Alejandro De La Torre

Phone: 713.441.6396

The primary purpose of this study is to evaluate the efficacy and safety of a single intravenous (IV) re-induction dose of approximately 6 milligram per kilogram (mg/kg) ustekinumab in participants with secondary loss of response (LoR) to subcut ... Read more >

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Alejandro De La Torre

Phone: 713.441.6396

This is an extension study to evaluate safety and efficacy of ozanimod in participants with moderately to severely active Crohn's Disease. ... Read more >

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Rosa Maria Barroso Da Costa

Phone: 713.363.7536

The purpose of this study is to compare the incidence of lymphoma in adult participants with moderate-to-severe ulcerative colitis who are treated with Simponi versus those treated with thiopurines. ... Read more >

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Mayyadah Al-Sabbagh

Phone: 346.238.0307

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Second ... Read more >

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Alejandro De La Torre

Phone: 713.441.6396

This is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease. ... Read more >

Status: Open Not Enrolling

Investigator: Bincy Abraham

Study Coordinator: Alejandro De La Torre

Phone: 713.441.6396

This open-label extension and safety monitoring study is composed of two parts: Part 1 will evaluate the long-term safety and efficacy of continued etrolizumab treatment in participants with moderately to severely active Crohn's disease who were ... Read more >

Status: Enrolling

Investigator: Bincy Abraham

Study Coordinator: Rosa Maria Barroso Da Costa

Phone: 713.363.7536

A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part ... Read more >